Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
NCT ID: NCT06749327
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
330 participants
INTERVENTIONAL
2025-10-01
2029-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Ultra-processed Foods on Cardiometabolic Risk Factors
NCT06538831
The Efficacy of Individualized Dietary Advice in Improving Diet Quality and Cardiovascular Health
NCT03854461
A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity
NCT05627570
Dietary Intervention Study on Food Based Dietary Guidelines for Sustainable and Healthy Lifestyles
NCT05253547
Perceptions of and Reactions to Ultra-Processed Menu Label Designs
NCT07214805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The current study aims to isolate the health effects of food processing from those of diet quality through the conduct of a dietary intervention study.
To isolate the health effects of food processing, the investigators propose to use healthy plant-based diets as the "base" diet. The investigators propose to initially discover plasma metabolomic features responsive to improved hPDI adherence and then conduct a dietary intervention trial to evaluate the impact of UPF consumption, in the setting of a high hPDI diet, on cardiometabolic outcomes and metabolic pathways.
The study will consist of a run-in phase where participants with a low adherence to a plant based diet will be randomized into (1) an intervention group that will receive diet counselling to follow a high hPDI diet over a period of 6 weeks and (2) a control group that will consume their usual diet (low hPDI). Both arms will be advised to avoid ultra processed food (UPF) consumption. Assuming 15% attrition, the study will enrol 118 participants for the run-in phase. Individuals with a high adherence to plant based diet will follow their normal diet for the 6 weeks of this run-in phase and then will be randomised into the main 4 month study.
In the main four month study, a randomized controlled parallel group dietary intervention will be conducted in participants with high hPDI in Ireland (North and South) to evaluate the impact of UPF consumption, in the context of a high hPDI diet, on cardiometabolic outcomes such as glycated haemoglobin and total cholesterol, and metabolic pathways. Participants will be randomized into one of 2 groups: high UPF hPDI diet or low UPF hPDI diet. Assuming an attrition rate of 15%, the study will enrol \~212 individuals to achieve a sample size of 180 participants who will complete the trial.
Randomization will be performed using a randomization scheme generated using www.randomization.com with random block sizes by research staff independent of the study. The investigators will stratify randomization according to age and BMI.
Power calculation : Assuming a change in total cholesterol of 9 mg/dL at four months and assuming a SD of change of 20, a total of 78 participants in each group is needed. Allowing for participant dropout of 15%, which is similar to that observed in the investigator's previous interventions, gives an overall sample size of 180.
Based on an SD of difference in change in HbA1c of 0.3%, the same sample size could detect as statistically significant a difference in HBA1c of 0.15% between the two intervention groups at four months.
The total number of participants that will be enrolled will be 330: 118 (run-in phase) and 212 (4 month trial).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High UPF, high hPDI diet
High ultra-processed foods (UPFs) and healthy plant based diet
High UPF, high hPDI diet
High ultra-processed foods (UPFs) and healthy plant based diet
Low UPF, high hPDI diet
Low ultra-processed foods (UPFs) and high healthy plant-based diet
Low UPF, high hPDI diet
Low ultra-processed foods (UPFs) and high healthy plant-based diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High UPF, high hPDI diet
High ultra-processed foods (UPFs) and healthy plant based diet
Low UPF, high hPDI diet
Low ultra-processed foods (UPFs) and high healthy plant-based diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Individuals will be screened for their adherence to the Plant based diet Index (PDI ).
1. Individuals with low adherence will enter run-in phase only (6 weeks)
2. Individuals with high adherence will enter the main intervention (4 months)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Dublin
OTHER
Harvard School of Public Health (HSPH)
OTHER
Queen's University, Belfast
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jayne Woodside, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof. Lorraine Brennan, PhD
Role: PRINCIPAL_INVESTIGATOR
University College Dublin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College Dublin
Dublin, Ireland, Ireland
Centre for Public Health, Queen's University Belfast
Belfast, Northern Ireland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Professor Lorraine Brennan, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TBC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.